Haemonetics's total assets for Q1 2026 were $2.46B, an increase of 0.45% from the previous quarter. HAE total liabilities were $1.58B for the fiscal quarter, a -3.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.